124 related articles for article (PubMed ID: 16562670)
21. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
22. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
Tang Y; Deng C; Du Q; Li G
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
[TBL] [Abstract][Full Text] [Related]
23. [Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].
Villalobos C; Rivera S; Weir-Medina J; Hassanhi M; Montiel M; González R
Invest Clin; 2003 Dec; 44(4):283-9. PubMed ID: 14727382
[TBL] [Abstract][Full Text] [Related]
24. Minimal residual disease in leukaemia.
Kumar L
Natl Med J India; 1995; 8(4):150-3. PubMed ID: 7633307
[No Abstract] [Full Text] [Related]
25. Twenty-five Zambians with leukaemias.
Fleming AF
East Afr Med J; 1989 Mar; 66(3):162-6. PubMed ID: 2591324
[TBL] [Abstract][Full Text] [Related]
26. [Expression of P27(Kip1) and its clinical significance in acute and chronic leukemia].
Lu RN; Sheng RL; Li JY; Zhu GR; Ding XJ; Zhu LL; Su EB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):291-7. PubMed ID: 15228653
[TBL] [Abstract][Full Text] [Related]
27. [The relationship of apolipoprotein H gene polymorphism with stroke].
Xia J; Yang QD; Yang QM; Xu HW; Zhang L
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):537-40. PubMed ID: 12887738
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D].
Tang JH; Gu SL; Zhang XJ
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):95-7. PubMed ID: 12536633
[TBL] [Abstract][Full Text] [Related]
29. Adult leukaemia--making the diagnosis.
De Boer R; Grigg A
Aust Fam Physician; 1994 Aug; 23(8):1508-11, 1514-5, 1518. PubMed ID: 7980150
[TBL] [Abstract][Full Text] [Related]
30. [Examination of human herpesvirus-6 antibody in blood patients serum].
Wang D; Xiao Y; Luo M; Zhang X
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):198-200. PubMed ID: 11938792
[TBL] [Abstract][Full Text] [Related]
31. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
[TBL] [Abstract][Full Text] [Related]
32. Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis.
Thorpe KL; Schafer AJ; Génin E; Trowsdale J; Beck S
Immunogenetics; 1999 Apr; 49(4):256-65. PubMed ID: 10079288
[TBL] [Abstract][Full Text] [Related]
33. [Pathological features of neuroleukemia. Changes and lessons].
Garzuly F
Orv Hetil; 1994 Jun; 135(24):1291-5. PubMed ID: 8015823
[TBL] [Abstract][Full Text] [Related]
34. [PCR/SSCP used as a complementary method for HLA oligotyping].
Tian W; Guo S; Li L
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):361-4. PubMed ID: 11189394
[TBL] [Abstract][Full Text] [Related]
35. Frequencies of HLA-DP alleles in the four major types of leukaemia.
Pawelec G; Rehbein A; Schaudt K; Busch FW
Tissue Antigens; 1989 Aug; 34(2):138-40. PubMed ID: 2514465
[TBL] [Abstract][Full Text] [Related]
36. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies].
Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
38. Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis.
Du X; Cai J; Zhou JZ; Stevens VL; Low MG
Biochem J; 2002 Jan; 361(Pt 1):113-8. PubMed ID: 11742535
[TBL] [Abstract][Full Text] [Related]
39. Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
Bäsecke J; Griesinger F; Trümper L; Brittinger G
Ann Hematol; 2002 Feb; 81(2):64-75. PubMed ID: 11907785
[TBL] [Abstract][Full Text] [Related]
40. Modelling lymphocytic leukaemia incidence in England and Wales using generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon and Knudson.
Little MP; Muirhead CR; Stiller CA
Stat Med; 1996 May; 15(10):1003-22. PubMed ID: 8783438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
